Bio

Dr. Mengni Guo is a medical oncologist in the Division of Oncology at Stanford University School of Medicine and a member of the Stanford Breast Cancer Program. She specializes in the care of patients with breast cancer, from active treatment through long-term survivorship. Dr. Guo emphasizes an individualized, team-based approach, working closely with patients and multidisciplinary specialists to develop treatment plans that reflect each patient’s clinical needs, personal values, and long-term quality of life.

Dr. Guo’s research focuses on breast cancer survivorship, particularly metabolic health during and after cancer treatment and the prevention and management of long-term treatment effects. She also uses large real-world datasets to study breast cancer treatment patterns and outcomes and to identify strategies to improve long-term health after cancer therapy. Her research has been presented at national meetings, including the American Society of Clinical Oncology (ASCO) Annual Meeting.

Clinical Focus

  • Oncology

Academic Appointments

Honors & Awards

  • Conquer Cancer Merit Award, American Society for Clinical Oncology (2026)
  • ASCO/AACR Methods in Clinical Cancer Research Workshop, American Society of Clinical Oncology / American Association for Cancer Research (2025)
  • Fellows Travel Award, OncLive National Fellows Forum (2025)
  • Resident CAPI Research Excellence Award, AdventHealth Orlando (2023)

Professional Education

  • Fellowship: Loma Linda University (2026) CA
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2023)
  • Residency: AdventHealth Florida (2023) FL
  • Internship: Peking Union Medical College (2014) China
  • Medical Education: Peking Union Medical College (2013) China

Contact

  • Clinical (Primary)  Stanford Women's Cancer Center 900 Blake Wilbur Dr 1st Fl MC 5854 Palo Alto, CA 94304 (650) 497-0736 (fax)

Additional Clinical Info

Additional Info